Saturday, May 9, 2009
Thursday, April 30, 2009
Mexican Flu Outbreak 2009: SPECIAL REPORT by Dr Leonard Horowitz
This unprecedented H1N1-H5N1 flu outbreak implicates the Ango-American Vaccine Pipeline, says world leading consumer health protector, Dr. Leonard Horowitz
Consider the skyrocketing stock values of Novavax, Inc., precipitated by dozens of alleged flu deaths in Mexico. Then investigate the leading Anglo-American network of genetic engineers manipulating, mutating, and distributing these viruses. The evidence compels you, for the benefit of public health and safety to seriously consider, even decree, a conspiracy to commit genocide, according to this Harvard trained expert in emerging diseases.
Here, Dr. Horowitz urges an investigation of Dr. James S. Robertson, Englands leading bioengineer of flu viruses for the vaccine industry, and avid promoter of U.S. Government funding for lucrative biodefense contracts, along with collaborators at the US Centers for Disease Control & Prevention (CDC). These suspects helped Novavax, Inc., in Bethesda, Maryland, produce genetically-modified recombinants of the avian, swine, and Spanish flu viruses, H5N1 and H1N1, nearly identical to the unprecedented Mexican virus that is allegedly spreading to the United States at the time of this posting. The outbreak was precisely timed to promote the companys new research and huge vaccine stockpiling contracts.
Scientists at the U.S. Centers for Disease Control (CDC) are implicated through collaborations and publications involving private contracts with Novavax, a company that obtains its biosimulars through CDC Influenza Branch director, Ruben O. Donis, and Dr. Rick Bright, previously working with Donis at the CDC, now Novavaxs Vice President of Global Influenza Programs.
Descriptions of this virus is pathognomonic, or diagnostic, of a virus that came from Robertsons circle of friends, Dr. Horowitz charges. No other group in the world takes H5N1 Asian flu infected chickens, brings them to Europe, extracts their DNA, combines their proteins with H1N1 viruses from the 1918 Spanish flu isolate, additionally mixes in swine flu genes from pigs, then reverse engineers them to infect humans. The end product could only have ended up in Mexico via the United States from Britain in care of the CDC. The CDC had to have sent them to Novavax, where Rick Brights team is now implicated in a conspiracy to commit genocide—the mass killing of people for profit.
Consider the skyrocketing stock values of Novavax, Inc., precipitated by dozens of alleged flu deaths in Mexico. Then investigate the leading Anglo-American network of genetic engineers manipulating, mutating, and distributing these viruses. The evidence compels you, for the benefit of public health and safety to seriously consider, even decree, a conspiracy to commit genocide, according to this Harvard trained expert in emerging diseases.
Here, Dr. Horowitz urges an investigation of Dr. James S. Robertson, Englands leading bioengineer of flu viruses for the vaccine industry, and avid promoter of U.S. Government funding for lucrative biodefense contracts, along with collaborators at the US Centers for Disease Control & Prevention (CDC). These suspects helped Novavax, Inc., in Bethesda, Maryland, produce genetically-modified recombinants of the avian, swine, and Spanish flu viruses, H5N1 and H1N1, nearly identical to the unprecedented Mexican virus that is allegedly spreading to the United States at the time of this posting. The outbreak was precisely timed to promote the companys new research and huge vaccine stockpiling contracts.
Scientists at the U.S. Centers for Disease Control (CDC) are implicated through collaborations and publications involving private contracts with Novavax, a company that obtains its biosimulars through CDC Influenza Branch director, Ruben O. Donis, and Dr. Rick Bright, previously working with Donis at the CDC, now Novavaxs Vice President of Global Influenza Programs.
Descriptions of this virus is pathognomonic, or diagnostic, of a virus that came from Robertsons circle of friends, Dr. Horowitz charges. No other group in the world takes H5N1 Asian flu infected chickens, brings them to Europe, extracts their DNA, combines their proteins with H1N1 viruses from the 1918 Spanish flu isolate, additionally mixes in swine flu genes from pigs, then reverse engineers them to infect humans. The end product could only have ended up in Mexico via the United States from Britain in care of the CDC. The CDC had to have sent them to Novavax, where Rick Brights team is now implicated in a conspiracy to commit genocide—the mass killing of people for profit.
CDC to mix avian, human flu viruses in pandemic study
Jan 14, 2004 (CIDRAP News) – One of the worst fears of infectious disease experts is that the H5N1 avian influenza virus now circulating in parts of Asia will combine with a human-adapted flu virus to create a deadly new flu virus that could spread around the world.
That could happen, scientists predict, if someone who is already infected with an ordinary flu virus contracts the avian virus at the same time. The avian virus has already caused at least 48 confirmed human illness cases in Asia, of which 35 have been fatal. The virus has shown little ability to spread from person to person, but the fear is that a hybrid could combine the killing power of the avian virus with the transmissibility of human flu viruses.
Now, rather than waiting to see if nature spawns such a hybrid, US scientists are planning to try to breed one themselves—in the name of preparedness.
The Centers for Disease Control and Prevention (CDC) will soon launch experiments designed to combine the H5N1 virus and human flu viruses and then see how the resulting hybrids affect animals. The goal is to assess the chances that such a "reassortant" virus will emerge and how dangerous it might be.
CDC officials confirmed the plans for the research as described recently in media reports, particularly in a Canadian Press (CP) story.
Two ways to make hybrids
The plans call for trying two methods to create hybrid viruses, CDC spokesman David Daigle told CIDRAP News via e-mail. One is to infect cells in a laboratory tissue culture with H5N1 and human flu viruses at the same time and then watch to see if they mix. For the human virus, investigators will use A (H3N2), the strain that has caused most human flu cases in recent years, according to the CP report.
The other method is reverse genetics—assembling a new virus with sets of genes from the H5N1 and H3N2 viruses. Reverse genetics has already been used to create H5N1 candidate vaccines in several laboratories, according to Daigle. The National Institutes of Health (NIH) said recently it would soon launch a clinical trial of one of those vaccines.
Of the two methods, the co-infection approach was described as slower and more laborious, though closer to what happens in nature.
Any viable viruses that emerge from these processes will be seeded into animals that are considered good models for testing how flu viruses behave in humans, according to Daigle. The aim will be to observe whether the animals get sick and whether infected animals can infect others.
The World Health Organization (WHO) has been "pleading" for laboratories to do this research, because it could provide some evidence to back up the agency's warnings about the risk of a flu pandemic, according to the CP report.
Klaus Stohr, head of the WHO's global influenza program, was quoted as saying that if none of the hybrids caused disease, the agency might be inclined to dial down its level of concern. But if the experiments produce highly transmissible and pathogenic viruses, the agency will be more worried, he said.
Safety precautions
Because of the obvious risks in creating viruses with the potential to spark a pandemic, the work will be done in a biosafety level 3 (BSL-3) laboratory at the CDC in Atlanta, Daigle told CIDRAP News.
"We recognize that there is concern by some over this type of work. This concern may be heightened by reports of recent lab exposures in other lab facilities," he said. "But CDC has an incredible record in lab safety and is taking very strict precautions."
Daigle said the US Department of Agriculture requires that highly pathogenic avian influenza (HPAI) viruses be treated as "Select Agents" and that research on them must be done in BSL-3 labs with "enhancements." These include "special provisions to protect both laboratory workers and the environment."
BSL-3 is the second highest level of laboratory biosecurity. It is used for work with pathogens that may cause serious or potentially lethal disease if inhaled, such as tuberculosis or St. Louis encephalitis, according to the CDC.
CDC experiments with HPAI viruses have to pass reviews by the agency's Institutional Biosafety Committee and Animal Care and Use Committee, Daigle said. The facilities involved are inspected by the USDA and the CDC's Office of Safety and Health, and staff members who work with Select Agents require special clearance.
It's been done before
The upcoming experiments will not break entirely new ground for the CDC, the CP story revealed. The agency already has made hybrid viruses with H5N1 samples isolated from patients in Hong Kong in 1997, when the virus first caused human disease.
The results of that research have not yet been published, and the CDC has said little about them. In the CP report, Dr. Nancy Cox, head of the CDC's influenza branch, commented only, "Some gene combinations could be produced and others could not."
Daigle added little to that. He said, "The reassortment work with the 1997 isolate was intermittently interrupted with SARS [severe acute respiratory syndrome] and then the 2004 H5N1 outbreak. We are currently concentrating our efforts on understanding the pathogenicity of the 2004 strains (non-reassortants) in mammalian models."
He said the CDC hopes to prepare a report on that research "in the near future."
http://www.cidrap.umn.edu/cidrap/content/influenza/panflu/news/jan1404hybrids.html
See also:
CDC information on biosafety levels
http://www.cdc.gov/od/ohs/symp5/jyrtext.htm
That could happen, scientists predict, if someone who is already infected with an ordinary flu virus contracts the avian virus at the same time. The avian virus has already caused at least 48 confirmed human illness cases in Asia, of which 35 have been fatal. The virus has shown little ability to spread from person to person, but the fear is that a hybrid could combine the killing power of the avian virus with the transmissibility of human flu viruses.
Now, rather than waiting to see if nature spawns such a hybrid, US scientists are planning to try to breed one themselves—in the name of preparedness.
The Centers for Disease Control and Prevention (CDC) will soon launch experiments designed to combine the H5N1 virus and human flu viruses and then see how the resulting hybrids affect animals. The goal is to assess the chances that such a "reassortant" virus will emerge and how dangerous it might be.
CDC officials confirmed the plans for the research as described recently in media reports, particularly in a Canadian Press (CP) story.
Two ways to make hybrids
The plans call for trying two methods to create hybrid viruses, CDC spokesman David Daigle told CIDRAP News via e-mail. One is to infect cells in a laboratory tissue culture with H5N1 and human flu viruses at the same time and then watch to see if they mix. For the human virus, investigators will use A (H3N2), the strain that has caused most human flu cases in recent years, according to the CP report.
The other method is reverse genetics—assembling a new virus with sets of genes from the H5N1 and H3N2 viruses. Reverse genetics has already been used to create H5N1 candidate vaccines in several laboratories, according to Daigle. The National Institutes of Health (NIH) said recently it would soon launch a clinical trial of one of those vaccines.
Of the two methods, the co-infection approach was described as slower and more laborious, though closer to what happens in nature.
Any viable viruses that emerge from these processes will be seeded into animals that are considered good models for testing how flu viruses behave in humans, according to Daigle. The aim will be to observe whether the animals get sick and whether infected animals can infect others.
The World Health Organization (WHO) has been "pleading" for laboratories to do this research, because it could provide some evidence to back up the agency's warnings about the risk of a flu pandemic, according to the CP report.
Klaus Stohr, head of the WHO's global influenza program, was quoted as saying that if none of the hybrids caused disease, the agency might be inclined to dial down its level of concern. But if the experiments produce highly transmissible and pathogenic viruses, the agency will be more worried, he said.
Safety precautions
Because of the obvious risks in creating viruses with the potential to spark a pandemic, the work will be done in a biosafety level 3 (BSL-3) laboratory at the CDC in Atlanta, Daigle told CIDRAP News.
"We recognize that there is concern by some over this type of work. This concern may be heightened by reports of recent lab exposures in other lab facilities," he said. "But CDC has an incredible record in lab safety and is taking very strict precautions."
Daigle said the US Department of Agriculture requires that highly pathogenic avian influenza (HPAI) viruses be treated as "Select Agents" and that research on them must be done in BSL-3 labs with "enhancements." These include "special provisions to protect both laboratory workers and the environment."
BSL-3 is the second highest level of laboratory biosecurity. It is used for work with pathogens that may cause serious or potentially lethal disease if inhaled, such as tuberculosis or St. Louis encephalitis, according to the CDC.
CDC experiments with HPAI viruses have to pass reviews by the agency's Institutional Biosafety Committee and Animal Care and Use Committee, Daigle said. The facilities involved are inspected by the USDA and the CDC's Office of Safety and Health, and staff members who work with Select Agents require special clearance.
It's been done before
The upcoming experiments will not break entirely new ground for the CDC, the CP story revealed. The agency already has made hybrid viruses with H5N1 samples isolated from patients in Hong Kong in 1997, when the virus first caused human disease.
The results of that research have not yet been published, and the CDC has said little about them. In the CP report, Dr. Nancy Cox, head of the CDC's influenza branch, commented only, "Some gene combinations could be produced and others could not."
Daigle added little to that. He said, "The reassortment work with the 1997 isolate was intermittently interrupted with SARS [severe acute respiratory syndrome] and then the 2004 H5N1 outbreak. We are currently concentrating our efforts on understanding the pathogenicity of the 2004 strains (non-reassortants) in mammalian models."
He said the CDC hopes to prepare a report on that research "in the near future."
http://www.cidrap.umn.edu/cidrap/content/influenza/panflu/news/jan1404hybrids.html
See also:
CDC information on biosafety levels
http://www.cdc.gov/od/ohs/symp5/jyrtext.htm
Indonesia floats idea of man-made swine flu
Tue, 28 Apr 2009 09:46:25 GMT
As swine flu continues to take its toll, claims surface that the deadly four-part flu virus could have been created for "bio-terror attacks."
Speaking at a conference to reassure the public over hers government's response to the swine flu threat, Indonesian Heath Minister Siti Fadilah Supari said Tuesday that the controversial virus could have been man-made.
She declined to elaborate on her claim but she had previously accused Western governments of making and spreading viruses in the developing world to boost pharmaceutical companies' profits, AFP reported.
"I'm not sure whether the virus was genetically engineered but it's a possibility," Supari said.
Supari assured Indonesians that the deadly virus could not survive in tropical countries like Indonesia which was the worst hit country by the bird flu virus.
"H1N1 survives in countries with four seasons. The type A H1N1 virus hopefully won't be able to sustain itself once it enters the tropical climate of Indonesia," she added.
No cases of swine flu have been reported in Indonesia. It has banned imports of live pigs and pork products.
The World Health Organization (WHO) has raised its pandemic alert to level four, which means the virus is capable of significant human-to-human transmission. The virus has so far killed nearly 150 people in Mexico and has been reported in eleven countries, including Mexico, the US and Spain.
Several other countries from Colombia to New Zealand are investigating suspected cases.
Health experts say the virus comes from the same strain of virus that causes seasonal outbreaks in humans. They point out that this newly-detected version, which is highly contagious and fast-mutating, also contains
genetic material from the types of influenza that afflict swine and birds.
As swine flu continues to take its toll, claims surface that the deadly four-part flu virus could have been created for "bio-terror attacks."
Speaking at a conference to reassure the public over hers government's response to the swine flu threat, Indonesian Heath Minister Siti Fadilah Supari said Tuesday that the controversial virus could have been man-made.
She declined to elaborate on her claim but she had previously accused Western governments of making and spreading viruses in the developing world to boost pharmaceutical companies' profits, AFP reported.
"I'm not sure whether the virus was genetically engineered but it's a possibility," Supari said.
Supari assured Indonesians that the deadly virus could not survive in tropical countries like Indonesia which was the worst hit country by the bird flu virus.
"H1N1 survives in countries with four seasons. The type A H1N1 virus hopefully won't be able to sustain itself once it enters the tropical climate of Indonesia," she added.
No cases of swine flu have been reported in Indonesia. It has banned imports of live pigs and pork products.
The World Health Organization (WHO) has raised its pandemic alert to level four, which means the virus is capable of significant human-to-human transmission. The virus has so far killed nearly 150 people in Mexico and has been reported in eleven countries, including Mexico, the US and Spain.
Several other countries from Colombia to New Zealand are investigating suspected cases.
Health experts say the virus comes from the same strain of virus that causes seasonal outbreaks in humans. They point out that this newly-detected version, which is highly contagious and fast-mutating, also contains
genetic material from the types of influenza that afflict swine and birds.
Subscribe to:
Posts (Atom)